1. Home
  2. SPCB vs LSTA Comparison

SPCB vs LSTA Comparison

Compare SPCB & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • LSTA
  • Stock Information
  • Founded
  • SPCB 1988
  • LSTA 1980
  • Country
  • SPCB Israel
  • LSTA United States
  • Employees
  • SPCB N/A
  • LSTA N/A
  • Industry
  • SPCB Semiconductors
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • SPCB Technology
  • LSTA Health Care
  • Exchange
  • SPCB Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • SPCB 31.4M
  • LSTA 31.2M
  • IPO Year
  • SPCB N/A
  • LSTA N/A
  • Fundamental
  • Price
  • SPCB $9.37
  • LSTA $2.64
  • Analyst Decision
  • SPCB Strong Buy
  • LSTA Strong Buy
  • Analyst Count
  • SPCB 1
  • LSTA 1
  • Target Price
  • SPCB $18.00
  • LSTA $15.00
  • AVG Volume (30 Days)
  • SPCB 780.5K
  • LSTA 72.4K
  • Earning Date
  • SPCB 11-14-2024
  • LSTA 02-27-2025
  • Dividend Yield
  • SPCB N/A
  • LSTA N/A
  • EPS Growth
  • SPCB N/A
  • LSTA N/A
  • EPS
  • SPCB 1.02
  • LSTA N/A
  • Revenue
  • SPCB $26,843,000.00
  • LSTA N/A
  • Revenue This Year
  • SPCB $6.72
  • LSTA N/A
  • Revenue Next Year
  • SPCB $16.91
  • LSTA N/A
  • P/E Ratio
  • SPCB $9.50
  • LSTA N/A
  • Revenue Growth
  • SPCB 5.23
  • LSTA N/A
  • 52 Week Low
  • SPCB $2.55
  • LSTA $2.19
  • 52 Week High
  • SPCB $18.95
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 46.90
  • LSTA 42.17
  • Support Level
  • SPCB $9.21
  • LSTA $2.45
  • Resistance Level
  • SPCB $11.43
  • LSTA $2.74
  • Average True Range (ATR)
  • SPCB 1.74
  • LSTA 0.32
  • MACD
  • SPCB -0.67
  • LSTA -0.05
  • Stochastic Oscillator
  • SPCB 1.64
  • LSTA 16.48

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: